Axsome Stock Is Flying as Fast-Acting Depression Drug Wins FDA Approval

Text size The decision on the drug came a bit less than a year after the FDA’s self-imposed deadline on making a call had passed. Dreamstime The Food and Drug Administration issued a long-awaite...

Axsome Therapeutics Stock Soars on Proposed FDA Labeling for Depression Drug

Text size Axsome is reviewing the proposed labeling from the FDA. Dreamstime Shares of Axsome Therapeutics were soaring Monday after the biopharmaceutical company announced some good news in an attemp...

Axsome Shares Sink After Canceling Broker Conference: Morgan Stanley

By Sam Boughedda Investing.com — Axsome Therapeutics Inc (NASDAQ:AXSM) stock plunged over 18% Friday, closing below $30. According to Morgan Stanley (NYSE:MS) analyst Vikram Purohit, the “...